Dynamic Technology Lab’s Rocket Pharmaceuticals RCKT Stock Holding History

Dynamic Technology Lab’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80K	Buy	+23,398	New	+$77.8K	0.02%	602
2026 Q1	–	Sell	-38,110	Closed	-$134K	–	1125
2025 Q4	$134K	Buy	38,110 +7,350	+24%	+$25.2K	0.03%	656
2025 Q3	$100K	Buy	+30,760	New	+$96.9K	0.02%	731
2025 Q2	–	Sell	-28,370	Closed	-$189K	–	1278
2025 Q1	$189K	Buy	+28,370	New	+$280K	0.03%	845
2022 Q2	–	Sell	-24,408	Closed	-$387K	–	1466
2022 Q1	$387K	Buy	+24,408	New	+$422K	0.05%	683
2021 Q4	–	Sell	-17,170	Closed	-$513K	–	1428
2021 Q3	$513K	Buy	+17,170	New	+$625K	0.06%	515
2021 Q2	–	Sell	-9,022	Closed	-$400K	–	1454
2021 Q1	$400K	Buy	+9,022	New	+$495K	0.05%	675
2016 Q4	–	Sell	-3,690	Closed	-$139K	–	1111
2016 Q3	$139K	Buy	+3,690	New	+$116K	0.04%	783

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dynamic Technology Lab's RCKT Position: Q2 2026 in Review

Dynamic Technology Lab opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 23,398 shares worth $80K. The stake represents 0.02% of the portfolio and ranks #602 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in RCKT as recently as Q4 2025.

Dynamic Technology Lab first reported a position in RCKT in Q3 2016 and has held it in 8 quarters since. The position peaked at $513K in Q3 2021. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Dynamic Technology Lab held 23,398 shares of Rocket Pharmaceuticals worth $80K as of Q2 2026.
Rocket Pharmaceuticals was a new Dynamic Technology Lab position in Q2 2026.
Rocket Pharmaceuticals made up 0.02% of Dynamic Technology Lab's portfolio in Q2 2026, its #602 holding.
Dynamic Technology Lab first reported a position in Rocket Pharmaceuticals in Q3 2016 and has held it in 8 quarters since.
Dynamic Technology Lab's Rocket Pharmaceuticals position peaked at $513K in Q3 2021.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.